{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:19:27Z","timestamp":1790392767308,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T00:00:00Z","timestamp":1124841600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Int Health Hum Rights"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Two planned trials of pre-exposure prophylaxis tenofovir in Cambodia and Cameroon to prevent HIV infection in high-risk populations were closed due to activist pressure on host country governments. The international news media contributed substantially as the primary source of knowledge transfer regarding the trials. We aimed to characterize the nature of reporting, specifically focusing on the issues identified by media reports regarding each trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>With the aid of an information specialist, we searched 3 electronic media databases, 5 electronic medical databases and extensively searched the Internet. In addition we contacted stakeholder groups. We included media reports addressing the trial closures, the reasons for the trial closures, and who was interviewed. We extracted data using content analysis independently, in duplicate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We included 24 reports on the Cambodian trial closure and 13 reports on the Cameroon trial closure. One academic news account incorrectly reported that it was an HIV vaccine trial that closed early. The primary reasons cited for the Cambodian trial closure were: a lack of medical insurance for trial related injuries (71%); human rights considerations (71%); study protocol concerns (46%); general suspicions regarding trial location (37%) and inadequate prevention counseling (29%). The primary reasons cited for the Cameroon trial closure were: inadequate access to care for seroconverters (69%); participants not sufficiently informed of risks (69%); inadequate number of staff (46%); participants being exploited (46%) and an unethical study design (38%). Only 3\/23 (13%) reports acknowledged interviewing research personnel regarding the Cambodian trial, while 4\/13 (30.8%) reports interviewed researchers involved in the Cameroon trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our review indicates that the issues addressed and validity of the media reports of these trials is highly variable. Given the potential impact of the media in formulation of health policy related to HIV, efforts are needed to effectively engage the media during periods of controversy in the HIV\/AIDS epidemic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-698x-5-6","type":"journal-article","created":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T18:13:57Z","timestamp":1124907237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Media reporting of tenofovir trials in Cambodia and Cameroon"],"prefix":"10.1186","volume":"5","author":[{"given":"Edward","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Rachlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumanan","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,24]]},"reference":[{"key":"20_CR1","unstructured":"UNAIDS: AIDS epidemic update. Geneva: UNAIDS. 2004"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1086\/322781","volume":"184","author":"KK Van Rompay","year":"2001","unstructured":"Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML: Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection. J Infect Dis. 2001, 184: 429-438. 10.1086\/322781.","journal-title":"J Infect Dis"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1086\/344360","volume":"186","author":"KK Van Rompay","year":"2002","unstructured":"Van Rompay KK, Schmidt KA, Lawson JR, Singh R, Bischofberger N, Marthas ML: Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus. J Infect Dis. 2002, 186: 1508-1513. 10.1086\/344360.","journal-title":"J Infect Dis"},{"key":"20_CR4","first-page":"136LB","volume-title":"12th Conference on Retroviruses and Opportunistic Infections","author":"S Subbarao","year":"2005","unstructured":"Subbarao S, Otten R, Ramos A, Jackson E, Adams D, Kim C, Bashirian S, Johnson J, Monsour M, Janssen R, Paxton L, Greenberg A, Folks T: Chemoprophylaxis with oral tenofovir disoproxil fumarate (TDF) delays but does not prevent infection in Rhesus Macaques given repeated rectal challenges of SIV. 12th Conference on Retroviruses and Opportunistic Infections. 2005, Boston, 136LB-"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.305.5687.1092a","volume":"305","author":"J Cohen","year":"2004","unstructured":"Cohen J: AIDS research. Cambodian leader throws novel prevention trial into limbo. Science. 2004, 305: 1092-10.1126\/science.305.5687.1092a.","journal-title":"Science"},{"key":"20_CR6","volume-title":"Science, Science Now","author":"J Cohen","year":"2005","unstructured":"Cohen J: Cameroon Suspends AIDS Study. Science, Science Now. 2005, Feb. 4, 2005"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1126\/science.307.5716.1708a","volume":"307","author":"J Cohen","year":"2005","unstructured":"Cohen J: AIDS clinical trials. More woes for novel HIV prevention approach. Science. 2005, 307: 1708-10.1126\/science.307.5716.1708a.","journal-title":"Science"},{"key":"20_CR8","volume-title":"The Wall Street Journal","author":"M Chase","year":"2004","unstructured":"Chase M: Key AIDS study in Cambodia now in jeopardy. The Wall Street Journal. 2004, New York"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1371\/journal.pmed.0020234","volume":"2","author":"JA Singh","year":"2005","unstructured":"Singh JA, Mills EJ: Abandoned trials of Pre-Exposure Prophylaxis for HIV: What went wrong?. PLOS Medicine. 2005, 2: e234-10.1371\/journal.pmed.0020234.","journal-title":"PLOS Medicine"},{"key":"20_CR10","volume-title":"CAMEROON: Clinical trial of anti-HIV drug on sex workers in question","author":"IRIN-News","year":"2005","unstructured":"IRIN-News: CAMEROON: Clinical trial of anti-HIV drug on sex workers in question. 2005, [http:\/\/www.irinnews.org\/report.asp?ReportID=45252&SelectRegion=West_Africa]"},{"key":"20_CR11","volume-title":"The Post News Line","author":"C Atatah","year":"2005","unstructured":"Atatah C: Douala AIDS Drug Controversy: Medical Council Says Trials Violated Ethical Norms. The Post News Line. 2005, [http:\/\/www.postnewsline.com\/2005\/02\/strongdouala_ai.html]"},{"key":"20_CR12","volume-title":"ACT-UP Paris","author":"ACT-UP-Paris","year":"2004","unstructured":"ACT-UP-Paris: tenofovir: inethical trial. ACT-UP Paris. 2004, [http:\/\/www.actupparis.org\/article1734.html]"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-4-1","volume":"4","author":"K Wilson","year":"2004","unstructured":"Wilson K, Code C, Dornan C, Ahmad N, Hebert P, Graham I: The reporting of theoretical health risks by the media: Canadian newspaper reporting of potential blood transmission of Creutzfeldt-Jakob disease. BMC Public Health. 2004, 4: 1-10.1186\/1471-2458-4-1.","journal-title":"BMC Public Health"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/1463677032000069709","volume":"22","author":"B Nerlich","year":"2003","unstructured":"Nerlich B, Clarke DD: Anatomy of a media event: how arguments clashed in the 2001 human cloning debate. New Genet Soc. 2003, 22: 43-59. 10.1080\/1463677032000069709.","journal-title":"New Genet Soc"},{"key":"20_CR15","volume-title":"AIDS Treatment News","author":"JS James","year":"2004","unstructured":"James JS: Cambodia stops important tenofovir prevention trial. AIDS Treatment News. 2004"},{"key":"20_CR16","volume-title":"Cambodian PM orders anti-AIDS drug test halted; cites human values","author":"K Munthit","year":"2004","unstructured":"Munthit K: Cambodian PM orders anti-AIDS drug test halted; cites human values. 2004, Phnom Penh: Canadian Press"},{"key":"20_CR17","first-page":"B1","volume-title":"Wall Street Journal","author":"MCaG Naik","year":"2004","unstructured":"Naik MCaG: Key AIDS Study in Cambodia Now in Jeopardy. Wall Street Journal. 2004, B1-B1"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(04)01159-4","volume":"4","author":"K Ahmad","year":"2004","unstructured":"Ahmad K: Trial of antiretroviral for HIV prevention on hold. The Lancet Infectious Diseases. 2004, 4: 597-10.1016\/S1473-3099(04)01159-4.","journal-title":"The Lancet Infectious Diseases"},{"key":"20_CR19","volume-title":"Nature Biotechnology","author":"H Stephan","year":"2004","unstructured":"Stephan H: Growing Pains in AIDS drug Development: HIV drug trial in Cambodia halted. Nature Biotechnology. 2004"},{"key":"20_CR20","volume-title":"The 7:30 report","author":"M McKew","year":"2004","unstructured":"McKew M: Drug Trial to start in Cambodia. The 7:30 report. 2004"},{"key":"20_CR21","volume-title":"San Francisco Chronicle","author":"S Russell","year":"2004","unstructured":"Russell S: AIDS Chicago Antiviral Drug Used to Treat AIDS to be tested as Vaccine. San Francisco Chronicle. 2004"},{"key":"20_CR22","volume-title":"Phnom Penh: LifeSiteNews","author":"JMO","year":"2004","unstructured":"JMO: Pro-abortion Group Thwarted in attempt to Test Dubious HIV drugs on Cambodian Prostitutes. Phnom Penh: LifeSiteNews. 2004"},{"key":"20_CR23","volume-title":"AIDSMAP","author":"K Alcorn","year":"2004","unstructured":"Alcorn K: Cambodian study of tenofovir for HIV prevention halted, PM cites 'human rights'. AIDSMAP. 2004"},{"key":"20_CR24","first-page":"A15","volume-title":"Dose of Prevention where HIV thrives: Nigeria Brothel is test site for new pill","author":"C Timberg","year":"2004","unstructured":"Timberg C: Dose of Prevention where HIV thrives: Nigeria Brothel is test site for new pill. 2004, Washington Post. Washington, A15-A15"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.305.5687.1092a","volume":"305","author":"J Cohen","year":"2004","unstructured":"Cohen J: Cambodian Leader Throws Novel Prevention Trial into Limbo. Science. 2004, 305: 1092-10.1126\/science.305.5687.1092a. 1092","journal-title":"Science"},{"key":"20_CR26","volume-title":"Scarlet Alliance","author":"E Jeffreys","year":"2004","unstructured":"Jeffreys E: Cambodian Sex Workers win against Bill Gates. Scarlet Alliance. 2004"},{"key":"20_CR27","volume-title":"Life Issues Net","author":"IN Comments","year":"2004","unstructured":"Comments IN: Cambodia's premier halts planned trials of AIDS drug. Life Issues Net. 2004"},{"key":"20_CR28","volume-title":"Positive Nation","author":"G Cairns","year":"2004","unstructured":"Cairns G: Sex Workers force end to drug trial. Positive Nation. 2004"},{"key":"20_CR29","volume-title":"Science and Development Network","author":"Canada.com","year":"2004","unstructured":"Canada.com: Cambodia's prime minister halts AIDS drug trial. Science and Development Network. 2004"},{"key":"20_CR30","volume-title":"AIDS Asia","author":"J Thomas","year":"2004","unstructured":"Thomas J: Cambodian HIV Clinical Trial impasse: UNAIDS mediation is essential. AIDS Asia. 2004"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrmicro1010","volume":"2","author":"D Ojcius","year":"2004","unstructured":"Ojcius D: HIV vaccine trial halted. Nat Rev Microbiol. 2004, 2: 776-10.1038\/nrmicro1010.","journal-title":"Nat Rev Microbiol"},{"key":"20_CR32","first-page":"A14","volume-title":"The Gazette","author":"K Munthit","year":"2004","unstructured":"Munthit K: PM wants anti-AIDS drug trials stopped. The Gazette. 2004, Montreal, A14-A14"},{"key":"20_CR33","unstructured":"Reenie S: The Gilead Saga. American Journal of Bioethics Editors Blog. February 18, 2005"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1200\/JCO.2004.02.150","volume":"22","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA: The ethics of early stopping rules: who is protecting whom?. J Clin Oncol. 2004, 22: 1542-1545. 10.1200\/JCO.2004.02.150.","journal-title":"J Clin Oncol"},{"key":"20_CR35","volume-title":"Douala: Aidsmap","author":"EJ Bernard","year":"2005","unstructured":"Bernard EJ: Cameroon study of tenofovir for HIV prevention suspended, Health Minister claims 'dysfunctions' in study protocol. Douala: Aidsmap. 2005"},{"key":"20_CR36","volume-title":"Yaounde: Integrated Regional Information Network","author":"AEGiS-IRIN","year":"2005","unstructured":"AEGiS-IRIN: CAMEROON: Clinical trial of anti-HIV drug on sex workers in question. Yaounde: Integrated Regional Information Network. 2005"},{"key":"20_CR37","volume-title":"Abidjan: VOA","author":"N Colombant","year":"2005","unstructured":"Colombant N: Cameroon Activists Want Protection of Drug Test Victims. Abidjan: VOA. 2005"},{"key":"20_CR38","volume-title":"AF-AIDS","author":"Coalition GCfMatAVA","year":"2005","unstructured":"Coalition GCfMatAVA: Statement on the PREP trials in Cambodia and Cameroon. AF-AIDS. 2005"},{"key":"20_CR39","volume-title":"Reply to posting by Act-UP Paris","author":"publique J-LR-Mds","year":"2004","unstructured":"publique J-LR-Mds: Reply to posting by Act-UP Paris. 2004"},{"key":"20_CR40","volume-title":"emed@usahealthgap.org","author":"R Samba-Kounzi","year":"2004","unstructured":"Samba-Kounzi R: emed@usahealthgap.org. 2004"},{"key":"20_CR41","volume-title":"Science and Development Network","author":"P Shetty","year":"2005","unstructured":"Shetty P: Cameroon suspends trial of AIDS drug after protests. Science and Development Network. 2005"},{"key":"20_CR42","volume-title":"Actions Treatments","author":"DCT Tall","year":"2005","unstructured":"Tall DCT: \"Gilead Scandal in Cameroun\" AfriCASO condemns. Actions Treatments. 2005"},{"key":"20_CR43","unstructured":"AF-AIDS: Tenofovir trials: Interview with Beth Robinson from FHI. HealthGap. February 5 2005"},{"key":"20_CR44","volume-title":"The Wall Street Journal","author":"M Chase","year":"2005","unstructured":"Chase M: AIDS-Preventative Test Halted by Cameroon Amid Protests. The Wall Street Journal. 2005"},{"key":"20_CR45","volume-title":"La nouvelle Expression","author":"V Simeon","year":"2005","unstructured":"Simeon V: SIDA: Le Scandale est dans l'eprouvette. La nouvelle Expression. 2005, Douala"},{"key":"20_CR46","unstructured":"AIDS drug trial stopped in Cambodia. Washington Times. 2004"},{"key":"20_CR47","unstructured":"Major HIV drug trial to be halted. BBC News. 2004"},{"key":"20_CR48","volume-title":"International Antiviral Therapy Evaluation Center","author":"C J","year":"2004","unstructured":"J C: The Asian Equation: One size doesn't fit all. International Antiviral Therapy Evaluation Center. 2004"},{"key":"20_CR49","volume-title":"BBC News","author":"B News","year":"2004","unstructured":"News B: Major HIV drug trial to be halted. BBC News. 2004"},{"key":"20_CR50","unstructured":"Cambodian sex workers reject HIV drug trials. Asian Labor News. 2004"},{"key":"20_CR51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(04)01159-4","volume":"4","author":"K Ahmad","year":"2004","unstructured":"Ahmad K: Trial of antiretroviral for HIV prevention on hold. Lancet Infect Dis. 2004, 4: 597-10.1016\/S1473-3099(04)01159-4.","journal-title":"Lancet Infect Dis"},{"key":"20_CR52","unstructured":"Ethics, drug trials and HIV: the case of tenofovir."},{"key":"20_CR53","first-page":"4","volume-title":"AIDS Treat News","author":"JS James","year":"2004","unstructured":"James JS: Cambodia stops important tenofovir prevention trial. AIDS Treat News. 2004, 4-5."},{"key":"20_CR54","volume-title":"Phase 2 trial of oral tenofovir use on a chemoprophylaxis for HIV infection in Nigeria: The outcome of community involvement with the scientific research process","author":"Group NHVaMA","year":"2004","unstructured":"Group NHVaMA: Phase 2 trial of oral tenofovir use on a chemoprophylaxis for HIV infection in Nigeria: The outcome of community involvement with the scientific research process. 2004"},{"key":"20_CR55","unstructured":"Sex workers trump Gates' humanitarian bid. Business Report. 2004 March 30"},{"key":"20_CR56","unstructured":"Munthit K: PM wants anti-AIDS drug trials stopped. The Gazette."},{"key":"20_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/267990","volume":"36","author":"M McCombs","year":"1972","unstructured":"McCombs M, Shaw D: The Agenda-Setting Function of the Mass Media. Public Opinion Quarterly. 1972, 36: 176-187. 10.1086\/267990.","journal-title":"Public Opinion Quarterly"},{"key":"20_CR58","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1097\/00002030-200411190-00003","volume":"18","author":"E Mills","year":"2004","unstructured":"Mills E, Cooper C, Guyatt G, Gilchrist A, Rachlis B, Sulway C, Wilson K: Barriers to participating in an HIV vaccine trial: a systematic review. Aids. 2004, 18: 2235-2242. 10.1097\/00002030-200411190-00003.","journal-title":"Aids"},{"key":"20_CR59","volume-title":"Presented at the 2005 Canadian HIV AIDS Research Conference","author":"EJ Mills","year":"2005","unstructured":"Mills EJ, Singh S, Dolma S, Nixon S, Kapoor S: Enrolling women into HIV prevention trials: A logistical challenge but ethical imperative. Presented at the 2005 Canadian HIV AIDS Research Conference. 2005, Vancouver"},{"key":"20_CR60","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(05)71857-2","volume":"365","author":"N Duan","year":"2005","unstructured":"Duan N: Listening to consumers and HIV vaccine preparedness. Lancet. 2005, 365: 1119-1121. 10.1016\/S0140-6736(05)71857-2.","journal-title":"Lancet"},{"key":"20_CR61","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/jme.2003.006981","volume":"30","author":"U Schuklenk","year":"2004","unstructured":"Schuklenk U: The standard of care debate: against the myth of an \"international consensus opinion\". J Med Ethics. 2004, 30: 194-197. 10.1136\/jme.2003.006981.","journal-title":"J Med Ethics"},{"key":"20_CR62","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jme.2003.006031","volume":"30","author":"RK Lie","year":"2004","unstructured":"Lie RK, Emanuel E, Grady C, Wendler D: The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. J Med Ethics. 2004, 30: 190-193. 10.1136\/jme.2003.006031.","journal-title":"J Med Ethics"},{"key":"20_CR63","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1056\/NEJM200006013422212","volume":"342","author":"R Steinbrook","year":"2000","unstructured":"Steinbrook R: Medical journals and medical reporting. N Engl J Med. 2000, 342: 1668-1671. 10.1056\/NEJM200006013422212.","journal-title":"N Engl J Med"},{"key":"20_CR64","first-page":"140","volume":"1","author":"J Lomas","year":"2000","unstructured":"Lomas J: Connecting Research and Policy. Canadian Journal of Policy Research. 2000, 1: 140-144.","journal-title":"Canadian Journal of Policy Research"},{"key":"20_CR65","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/S0140-6736(96)90947-2","volume":"347","author":"T Wilkie","year":"1996","unstructured":"Wilkie T: Sources in science: who can we trust?. Lancet. 1996, 347: 1308-1311. 10.1016\/S0140-6736(96)90947-2.","journal-title":"Lancet"},{"key":"20_CR66","unstructured":"Social Issues Research Centre, Royal Society, Royal Institution of Great Britain. Guidelines on science and health communication. Oxford: Social Issues Research Centre. 2001, Accessed April 28, 2005, [http:\/\/www.sirc.org\/publik\/revised_guidelines.shtml]"},{"key":"20_CR67","volume-title":"International AIDS Vaccine Initiative","author":"IAVI","year":"2005","unstructured":"IAVI: International AIDS Vaccine Initiative. 2005, Accessed April 28, 2005, [http:\/\/www.iavi.org]"}],"container-title":["BMC International Health and Human Rights"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-698X-5-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-698X-5-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-698X-5-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-698X-5-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:58:40Z","timestamp":1630486720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinthealthhumrights.biomedcentral.com\/articles\/10.1186\/1472-698X-5-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,24]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1186\/1472-698x-5-6","relation":{},"ISSN":["1472-698X"],"issn-type":[{"value":"1472-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,24]]},"assertion":[{"value":"19 May 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}